Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]
Good rotation makes weekly shots safer and more comfortable
Many GLP-1 medications, such as Ozempic, Wegovy, Zepbound, and Saxenda, have been linked to digestive side effects
For them a smaller, denser pack is the better deal even at a higher price per gram
What to do if your insurance wont cover your GLP-1 If insurance stopped covering your GLP-1 medication, do the following: 1
Weight Loss and Obesity Treatment In addition to their role in managing type 2 diabetes, GLP-1 agonists have gained significant attention for their potential in promoting weight loss and treating obesity